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Background: In March 2013, NHS England extended its national Bowel Cancer Screening Programme to include ‘one-off’ Flexible
Sigmoidoscopy screening (NHS Bowel Scope Screening, BSS) for men and women aged 55. With less than one in two people
currently taking up the screening test offer, there is a strong public health mandate to develop system-friendly interventions to
increase uptake while the programme is rolling out. This study aimed to assess the feasibility of sending a reminder to previous
BSS non-responders, 12 months after the initial invitation, with consideration for its potential impact on uptake.
Method: This study was conducted in the ethnically diverse London Boroughs of Brent and Harrow, where uptake is below the
national average. Between September and November 2014, 160 previous non-responders were randomly selected to receive a
reminder of the opportunity to self-refer 12 months after their initial invitation. The reminder included instructions on how to book
an appointment, and provided options for the time and day of the appointment and the gender of the endoscopist performing
the test. To address barriers to screening, the reminder was sent with a brief locally tailored information leaflet designed
specifically for this study. Participants not responding within 4 weeks were sent a follow-up reminder, after which there was no
further intervention. Self-referral rates were measured 8 weeks after the delivery of the follow-up reminder and accepted as final.
Results: Of the 155 participants who received the 12 months’ reminder (returned to sender, n¼ 5), 30 (19.4%) self-referred for an
appointment, of which 24 (15.5%) attended and were successfully screened. Attendance rates differed by gender, with significantly more
women attending an appointment than men (20.7% vs 8.8%, respectively; OR¼ 2.73, 95% CI¼ 1.02–7.35, P¼ 0.05), but not by area (Brent
vs Harrow) or area-level deprivation. Of the 30 people who self-referred for an appointment, 27 (90%) indicated a preference for a same-
sex practitioner, whereas three (10%) gave no preference. Preference for a same-sex practitioner was higher among women than men
(w2¼ 7.78, Po0.05), with only 67% of men (six of nine) requesting a same-sex practitioner, compared with 100% of women (n¼ 21).
Conclusions: Sending previous non-responders a 12 months’ reminder letter with a brief information leaflet is a feasible and
efficacious intervention, which merits further investigation in a randomised controlled trial.
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Colorectal cancer (CRC) is the fourth most common cancer in the
United Kingdom and the second leading cause of cancer deaths
(Cancer Research UK, 2015a, b). Screening can improve clinical
outcomes by detecting cases early, when they are easier to treat
(Logan et al, 2012; Cancer Research UK, 2014; Cancer Research
UK, 2015c. In addition, screening can prevent cases through the
timely detection and removal of adenomas (the precancerous
lesions from which most CRCs develop) (Leslie et al, 2002),
improving outcomes even further (Atkin et al, 2010; Whyte et al,
2012).
A recent appraisal of the options for CRC screening in England
highlighted that a combination of ‘once-only’ flexible sigmoido-
scopy (FS) at the age of 55, delivered in conjunction with the
current biennial faecal occult blood-testing strategy offered to
60–74-year olds, would be highly cost-effective, and would provide
significant reductions the incidence, mortality and treatment costs
associated with the disease (Whyte et al, 2012). As a result, NHS
England subsequently introduced ‘once-only’ FS screening for 55-
year olds (known as Bowel Scope Screening, BSS) to the National
Bowel Cancer Screening Programme in March 2013 (Department
of Health, 2012).
As with all screening programmes, the extent to which the cost
and public health benefits of including BSS are realised will depend
largely on uptake (Whyte et al, 2012; Geurts et al, 2015). In a
London-based pilot study, uptake of FS screening among the
invited population was 50% (Robb et al, 2010); if representative of
attendance in the national programme, it is expected that the
addition of FS would result in an additional 2000 CRC deaths and
10 000 CRC cases being prevented in England by mid-2030 (Geurts
et al, 2015). However, a recent analysis of uptake over the first 14
months of the programmes introduction revealed that only 43% of
the invited population attended a BSS appointment, and thereby
currently falls shy of the 50% benchmark (McGregor et al, 2015a).
Commonly cited reasons for not attending a FS appointment
include a lack of current health problems; practical barriers (i.e.,
inconvenient appointment time, difficulties travelling to the
appointment and so on); worry about pain, discomfort, or injury
associated with the examination; and not wanting to know about
any health issues (e.g., Vernon, 1997). For women specifically, the
gender of the practitioner performing the test has also been
reported as a potential barrier (Menees et al, 2005). In contrast to
the FOBt-screening programme, women have been found to be less
likely than men to have a FS (McGregor et al, 2015a), and the
anticipated gender of the endoscopist is considered to be a
contributing factor (Robb et al, 2010). Women have been found to
be more willing to have FS if the endoscopist is female (Farraye
et al, 2004) and are willing to wait longer for the test to ensure this
happens (Varadarajulu et al, 2002).
Similar to other screening programmes, the BSS programme
structure incorporates specific strategies to maximise uptake
(i.e., pre-notification letters, reminder letters and so on) (Baron
et al, 2008; Libby et al, 2011), but the test itself is unique in that it is
a ‘one-off’ procedure. Other screening programmes in England
invite people to be screened every few years (e.g., FOBt every 2
years, mammography every 3 years), allowing additional oppor-
tunities for people to take part (Steele et al, 2010; Lo et al, 2014). In
BSS, all adults are eligible to self-refer up to the age of 60, offering a
similar window of opportunity for those who do not take up the
initial invitation; however, there is no direct ‘reminder’ of this
possibility during the 5-year time frame.
This study, therefore aimed to examine the potential of a mailed
12 months’ self-referral reminder that addressed key barriers by
including an opportunity to choose the day and time of the
appointment and the gender of the endoscopist performing the
screening procedure. Because barriers to FS screening are unlikely
to exist in isolation (Jones et al, 2010), and combining
interventions that target CRC screening at a number of levels
yield greater results than they do if used individually (Hewitson
et al, 2011), additional barriers (e.g., anticipated pain) were
addressed with the inclusion of a FS information leaflet, designed
by a social marketing company, with a focus on engaging
individuals with low literacy using social cognitive approaches to
address misconceptions about screening (Bandura, 2004).
This study set out to test whether this strategy could be
implemented in a centre with below average uptake and, if so,
whether it met a minimum level of efficacy that would merit
further investigation in a randomised controlled trial (RCT).
A review of the methods and invitation process employed
was included in order to help refine the strategy in any
subsequent RCT.
MATERIALS AND METHODS
Study design and trial setting. We performed a single-centre
feasibility study at St. Mark’s Hospital in London. St. Mark’s
Hospital serves an ethnically diverse population with a high level of
socioeconomic deprivation; the majority (56%) of people invited to
take part in screening at St. Mark’s during the first 14 months were
living within either the most deprived areas in England (calculated
using census data for individual postcodes), or the most ethnically
diverse areas (74%; also calculated using census data for individual
postcodes) and, in total, only 40.5% of invitees attended an
appointment, which was significantly less than the national average
(43.5%) (McGregor et al, 2015a).
Study population. Eligible participants were men and women
registered with a General Practice in the London Boroughs of Brent
and Harrow who had not attended BSS within one year of their
initial invitation. Responders who had initially confirmed an
appointment but failed to attend were excluded from the study.
Sample size. To explore the feasibility of including a 12 months’
reminder in the routine operations of the centre, we set out to run
the study for a minimum of 10 weeks, with 16 previous non-
responders sent a reminder per week, giving a total sample size of
160 participants. The sample size also allowed us to test for a
minimum level of efficacy within the intervention arm, to check
whether investigation in a RCT was merited (minimum number of
self-referred appointments needed¼ 3), as well as obtain estimates
to inform the statistical parameters required to design such a study
(which would be powered to confirm the efficacy of the
intervention via a direct comparison with a control arm). The
A’Hern single-stage design, which is commonly used in smaller
studies with such aims (A’hern, 2001), confirmed that our sample
(n¼ 160) gave us acceptable levels for power (b40.8) and
significance (ao0.05) to test for a minimum level of efficacy,
with the unacceptable response rate based on the self-referral rate
of non-responders of the previous year (i.e., 0.35%), and the
desired response rate based on a 5% improvement (i.e., 5.35%).
Procedures. Eligible participants (n¼ 844) were identified on
the National Bowel Cancer Screening System (BCSS): an
electronic system which provides an up-to-date record of
individual-uptake data for patients enrolled in the national
screening programme. For a period of 10 weeks (September 2014
to November 2014), 16 people per week were randomly selected
for inclusion in the study from a variable weekly total of non-
responders using simple computerised pseudo-random selection
methods (Babbie, 2011).
Participants were mailed a ‘self-referral reminder letter’, along
with an ‘appointment–request slip’, information leaflet and
freepost return envelope B12 months after their initial invitation
(12 months reminder) (see Figure 1). Participants could book an
appointment either by returning their appointment–request slip,
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thereby initiating a call from a member of the administrative team
at the centre to confirm an appointment date, or by calling the
St. Mark’s Bowel Cancer Screening Centre directly on the Freephone
telephone number provided. Participants were able to indicate
their preferences for the gender of the endoscopist and the day and
time of the appointment, either on the appointment–request slip or
during the phone call to the Freephone number. Participants not
responding within 4 weeks of the 12 months’ reminder were sent a
second reminder (henceforth referred to as the ‘follow-up
reminder’), which again included an appointment–request slip,
the information leaflet and a freepost return envelope. After the
follow-up reminder, no further attempt to contact non-responding
participants was made. Participants were given a total of 12 weeks
(from receipt of the 12 months’ reminder) to respond before their
‘episode’ was closed: any self-referrals made after this time were
not included in the study results.
For those participants who made an appointment, a confirma-
tion letter and BSS consent form was sent to their home address.
The BSS consent form and confirmation letter used in this study
were the same as those used for routine appointments in the
national screening programme. Participants were asked to read
the BSS consent form, which contained information regarding the
risks and benefits of the procedure, before attending their
appointment, and to call the screening centre if they had any
questions. Participants were asked to bring the BSS consent form to
their appointment, where a specialist screening practitioner/
endoscopy nurse would discuss the risks of the procedure with
the individual to ensure an informed decision to be screened
was made.
The study was approved by the South Central Oxford B
Research Ethics Service (Ref: 14/SC/1246).
Intervention development. The materials used in this study
were designed in conjunction with ‘Resonant’: a social marketing
company which specialises in the development of health
behaviour change interventions (Resonant, 2015). The initial
content of the leaflet and reminder letter was informed by work
conducted by the UCL Research Team, which included a review
of the literature on patient-specific factors for non-attendance
(e.g., Vernon, 1997; Jones et al, 2010), and semi-structured
telephone interviews with people who had recently taken part in
the programme (n¼ 5; three female, two male). The semi-
structured telephone interviews were conducted with previously
screened adults to learn more about the key factors which
influenced the decision to be screened. Statements from the
interviews were then selected for use in the leaflet, with
permission from interviewees. Initial designs of the reminder
letter and leaflet were developed by Resonant and then tested in a
co-design workshop, facilitated by the company, in which
screening eligible adults from the London Boroughs of Brent
and Harrow (n¼ 4; three male, one female; ages 55–58) gave
feedback to inform future iterations. A revised version was then
presented to individuals who were either the eligible age or
approaching the eligible age for screening (n¼ 20; 12 female,
8 male, aged 50–59 years) and feedback obtained through
interviews conducted by a member of the UCL Research Team.
The final leaflet (see Supplementary Appendix 1) had a Flesch
readability score of 68.7, indicating that it was suitable for use
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Figure 1. BSS invitation flowchart with self-referral reminder added.
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within the general population (easily understood by 13–15-year
olds) (Kincaid et al, 1975).
12 months’ reminder letter. The 12 months’ reminder letter was
a personally addressed letter from St. Mark’s Hospital, which:
(1) invited participants to make a screening appointment by
returning an ‘appointment–request slip’ or by calling the Free-
phone telephone number for St. Mark’s Bowel Cancer Screening
Centre; (2) reminded participants that they had previously been
invited for an appointment 1 year earlier and were eligible to make
an appointment up until their 60th birthday; (3) gave participants
the opportunity to select a preference for the day and time of the
appointment and the gender of the practitioner performing the test
and; (4) highlighted three key messages: i) that the risk of
developing bowel cancer is highest in the patients’ age group
(55þ years), ii) screening is for people who do not have any signs
or symptoms of bowel cancer and iii) screening can help prevent
bowel cancer by removing small asymptomatic growths (called
polyps), which have the potential to become malignant over time
(see Supplementary Appendix 2).
Leaflet. The development of the leaflet was guided by two
psychological models of health behaviour that have previously
been used to explain individual level factors associated with
screening (e.g., perceived barriers and benefits) (Kiviniemi et al,
2011): the Health Belief Model (Rosenstock, 1974) and Social
Cognitive Theory (Bandura, 2004). In addition, the leaflet was
tailored to the London areas served by St. Mark’s hospital (i.e.,
included a map with information about local transport links to the
hospital). The leaflet also included an educational/knowledge-
building component to reinforce messages regarding the benefits of
screening (effectiveness and rationale), a descriptive social norms
message outlining uptake of BSS at St. Mark’s Hospital (‘270 people
screened every month’), and several practical components designed
to improve self-efficacy (i.e., instructions on how to book an
appointment and directions to the hospital). In addition, factors
previously found to increase screening intentions and participation
were incorporated into the design, for example, male/female
patient narratives (Jensen et al, 2014; McGregor et al, 2015b) (See
Table 1).
Follow-up reminder. A follow-up reminder letter was sent to
individuals not responding to the 12 months’ reminder within 4
weeks. This follow-up reminder repeated the information included
in the 12 months’ reminder, but also highlighted individuals had
recently received a reminder letter (see Supplementary Appendix 3).
Measures. Routinely available data stored on the BCSS were used
to verify self-referral and attendance 4 weeks following the
distribution of the 12 months’ reminder, and 8 weeks following
the distribution of the follow-up reminder. The BCSS was also
consulted to obtain the gender, area (Harrow or Brent) and an
area-based socioeconomic deprivation score for each participant.
Ethnicity is not routinely collected or available on the BCSS, and so
this information could not be extracted.
Socioeconomic deprivation was obtained by converting each
individual’s postcode to a score on the 2010 Index of Multiple
Deprivation (IMD) (Department for Communities and Local
Government, 2010). The IMD scores obtained were categorised
into tertiles of their national distributions. The IMD uses census-
derived indicators of income, education, employment, environ-
ment, health and disability, barriers to housing and services, and
Table 1. Characteristics of the reminder leaflet
Description
Motivational characteristics
Easy to read The Flesch formula was used to assess the readability of the leaflet, which gave it a score of 68.7
(equivalent of a 13–15-year reading age). Pilot participants indicated that the leaflet was ‘the right
length’, not ‘too positive’ and ‘included enough information to make a decision about screening’.
General Practitioner cancer lead endorsement The BSS programme was endorsed by the local general practitioner cancer lead for Hillingdon. A
photograph and quote of the GP were included: ‘I would urge anyone aged 55–59 to take this quick,
potentially lifesaving, one-off test that significantly reduces your risk of getting bowel cancer’.
Provincial social norms message The leaflet included a descriptive provincial social norms message: ‘About 270 people take up the
Bowel Scope Screening test at St. Mark’s Hospital every month’.
Effective communication of risk The antecedents and consequences of bowel cancer were used to communicate risk and explain the
preventative mechanisms of bowel scope screening: ‘Bowel cancer develops from polyps, which are
small growths in your bowel. Most polyps are harmless, but some can turn into cancer if left
untreated. By removing any polyps in your bowel during the test, bowel scope screening is a very
effective way of reducing the chance that you will get bowel cancer in the future’.
Patient narratives The leaflet included two patient narratives (one male, one female). Narratives have been associated
with a reduction in the perceived impact of barriers and increased perceived risk of CRC (Dillard et al,
2010), increased intention to be screened (McGregor et al, 2015b) and improved attendance at
colonoscopy screening (Jensen et al, 2014).
Female narrative: ‘I must admit I was nervous, but the specialist nurse explained everything very clearly.
It wasn’t painful at all. I was told I had no polyps and given the all clear, which was a huge relief. My
friend died from bowel cancer 5 years ago, so I was determined this wouldn’t happen to me!’
Male narrative: ‘The staff at St. Mark’s Hospital were great. The doctor found a polyp, which he
removed. I didn’t feel a thing. The doctor explained that polyps often don’t have any symptoms, so
people don’t always know if they have them. I’m glad they found the polyp before it had a chance to
become something more serious’.
Reducing worry about pain, discomfort and
embarrassment associated with the procedure
The leaflet was designed to reduce worry about pain, discomfort and embarrassment associated with
the procedure. Statements addressing pain were based on patient reported outcomes from the UK
FS pilot study: ‘The test is done in private and nearly everyone says it’s not embarrassing’; ‘Most
people say they felt no pain, or only mild pain’ (Robb et al, 2012).
Practical characteristics
Map and local transport options The leaflet was designed to address practical barriers to screening. A map of the area, and
description of local transport links to the hospital was included to help patients plan their journey.
Instructions on how to make an appointment Instructions on how to make an appointment by telephone referral were reiterated in the leaflet.
Patients were also informed they could call the St. Mark’s Freephone telephone number for further
information about the test.
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crime at small-area level to generate a scale ranging from 0 (least
deprived) to 80 (most deprived) (Department for Communities
and Local Government, 2010).
Analysis. Descriptive statistics were used to test whether the
number of self-referred appointments exceeded the threshold for
further investigation in a RCT. To explore possible variations of
the impact of the intervention in relation to deprivation, area and
gender, a multivariate logistic regression analysis was performed
(Engel, 1988). Differences in patient preferences for a same-sex
practitioner were examined by gender using the X2-test of
independence (Pearson, 1900); the data were analysed using SPSS
Statistics (version 22).
RESULTS
Sample characteristics. A total of 160 people (male¼ 71, 44.4%;
female¼ 89, 55.6%) were randomly selected to receive a 12
months’ self-referral reminder; however, five (3.1%) reminders
were found to be undeliverable and were ‘returned to sender’.
Subsequently, 155 people (male¼ 68, 43.9%, female¼ 87, 56.1%)
were monitored as part of this study (Figure 2). Variation by
locality and IMD score tertile are shown in Table 2.
BSS-screening referrals and attendance. A total of 30 (19.4%)
adults self-referred for BSS. Of these, 24 (80%) attended their
appointment and were screened, 3 (10%) did not attend, 2
cancelled and 1 did attend but was not screened owing to high
blood pressure (Figure 2). The overall attendance rate was
therefore 15.5% (24/155).
Attendance differed significantly by gender, with more women
attending an appointment than men (n¼ 21 (20.7%) vs n¼ 9
(8.8%), respectively; OR¼ 2.73, 95% CI¼ 1.02–7.35, P¼ 0.05).
There were no statistically significant differences between localities
(Brent vs Harrow) or tertiles of area-level deprivation (Table 3).
The self-referral attendance rate of eligible adults not included
in this feasibility trial during the study period was 1.2% (8/684).
Process evaluation
Self-referral method. Of the 30 people who self-referred for a BSS
appointment, 28 (93.3%) did so by returning the ‘appointment–
request slip’; the remaining two (6.7%) did so by calling the
provided Freephone telephone number.
Follow-up reminder reminder. A total of 21 people (13.5%)
responded to the self-referral reminder within 4 weeks. Subse-
quently, 134 follow-up reminders were sent with a further nine
(6.7%) responses received within the remaining 8-week response
844
Non-participants
identified via BCSS
16
Randomly selected each week to
receive a 12 months self-referral
reminder
684
Randomly
excluded
5
‘Returned to
sender’
24
Completed
screening in total
8
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0
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2
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0
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1
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Self-referrals made
9
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follow-up reminder
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self-referral reminder
2
DNA*
1
DNA*
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Figure 2. Basic design of the study.
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period. No responses were received beyond the 12-week cut-off
period.
Preference for day and time slot of appointment. Of the 30
people who self-referred for a BSS appointment, 24 (80%)
expressed a preference for a specific day and/or time. It was not
possible to accommodate preferences for 12 people (50%); only one
went on to cancel.
Preference for gender of practitioner. Of the 30 people who self-
referred for a BSS appointment, 27 (90%) indicated a preference
for a same-sex practitioner; none (0%) indicated a preference for a
practitioner of the opposite sex; and three (10%) gave no
preference. It was not possible to accommodate the preference of
eight (30%) people; however, no-one asked to be rescheduled.
Preferences for the sex of the practitioner were examined by
gender: women were significantly more likely to request a same-sex
practitioner than men, with all of the women who self-referred for
an appointment requesting a same-sex practitioner, compared with
two-thirds of men (100% vs 67%; w2¼ 7.78, Po0.05).
DISCUSSION
This feasibility study was initiated to test the format and potential
efficacy of incorporating a mailed self-referral reminder and locally
tailored information leaflet into the current BSS invitation process.
The reminder, when sent with the locally tailored information
leaflet 1 year after the participants’ initial invitation, facilitated
uptake in 15.5% of recipients, thereby exceeding the threshold for
further investigation in a RCT (n¼ 24 vs n¼ 3). The self-referral
rate for individuals not sent a 12 months’ reminder during the
study period was higher than anticipated (1.2% vs 0.35%); however,
our results would have exceeded the minimum level of efficacy
even assuming this higher rate (A’Hern, 2001).
The finding that this intervention is feasible and has the
potential to improve uptake by this group is highly important; if
the findings of this study were replicated in a large RCT, then this
simple intervention could have a considerable impact on uptake at
St. Mark’s Hospital. A self-referral rate of 15% among previous
non-responders would equate to an increase in overall uptake of
B9% (estimated by multiplying the proportion of adults not
responding to the initial invitation (0.6) by the proportion of adults
attending screening in response to the 12 months’ reminder
(0.15)). This would increase overall uptake at St. Mark’s to almost
50%. If similar rates are observed in a multicentre study, the
implementation of a 12 months’ reminder in the national
programme could have considerable public health benefits
(Geurts et al, 2015). Furthermore, additional reminders, possibly
at 24, 36 and 48 months’, have the potential to increase overall
uptake even further. Finally by a process of elimination such
additional reminders would target the most deprived population
and could ultimately reduce the socioeconomic gradient in
screening attendance.
Our study found that women were more likely to attend in
response to the reminder than men. The 12 months’ reminder,
therefore, has the potential to reduce the gender gap that has been
observed in response to the first invitation (McGregor et al, 2015a).
Previous research has indicated that for women particularly, the
possibility of having a male endoscopist leading the procedure is a
barrier to uptake (Menees et al, 2005), and so the option to allow
participants to communicate a preference for the gender of the
endoscopist is likely to have explicitly and directly addressed this
barrier, thereby encouraging women to re-consider BSS atten-
dance. In addition, it is also likely that the leaflet had a role in
facilitating uptake in women specifically, given that it was designed
to reduce barriers to FS, and women have been found to report
more barriers to the test than men (Wardle et al, 2005).
Although the proportions requesting a same-sex practitioner
between men and women were significantly different in our study,
the number of men and women self-referring in this study was
small (n¼ 9 and n¼ 21 respectively) and may not be representa-
tive of the proportions of men and women who would request a
same-sex practitioner in the general population. For instance, the
current study was set in an ethnically diverse area and so the
impact of the gender preference option may have been all the more
apparent here, as previous research has found the gender of the
endoscopist to be a pertinent barrier for black and ethnic minority
women (Varadarajulu et al, 2002). Future work should aim to
explore individual ethnicity when examining preferences for a
same-sex practitioner.
Previous research examining uptake of BSS in response to the
initial invitation has identified a strong socioeconomic gradient in
participation, with rates varying from 33% in the most deprived
areas to 53% in the least deprived (McGregor et al, 2015a). In this
study, we found no significant differences in participation between
tertiles of area-level deprivation (McGregor et al, 2015a); however,
it is important to note that the study was not designed to test for
differences between tertiles of area-level deprivation, and so may
have been underpowered to detect such differences. If the finding
were reproduced in a larger trial, the intervention examined in this
study may represent a potential strategy to reduce socioeconomic
inequalities within the national programme.
The main limitation of this study is that the intervention used
contained multiple components (including gender preference,
appointment preference and a locally tailored information leaflet),
and so without the appropriate control groups the contribution of
each factor to the success of the reminder could not be teased
apart. The next step would be to perform a RCT testing each of
these components with appropriate controls.
Table 2. Sample characteristics of the reminder population
n %
Gender
Male 68 43.9
Female 87 56.1
Area
Brent 76 49.0
Harrow 79 51.0
Tertile of deprivation (IMD score)
Tertile 1 (least deprived) 31 20
Tertile 2 62 40
Tertile 3 (most deprived) 62 40
Table 3. Uptake following the reminders by gender, tertiles
of the Index of Multiple Deprivation and location in the
eligible sample (n¼155)
Comparisons n attended (%) OR (95% CI) P-value
Overall (n¼155) 24 (15.5) — —
Gender
Male (n¼68) 6 (8.8) — —
Female (n¼87) 18 (20.7) 2.73 (1.02–7.35) 0.05
Location
Harrow (n¼79) 12 (15.2 ) — —
Brent (n¼76) 12 (15.8) 1.10 (0.35–3.40) 0.87
Tertile of deprivation
1 (n¼ 32, least deprived ) 4 (12.5) — —
2 (n¼ 64) 11 (17.2) 1.46 (0.39–5.51) 0.57
3 (n¼63, most deprived) 9 (14.3) 1.08 (0.22–5.37) 0.93
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One potential concern regarding the leaflet used in this study is
that information within was not balanced. It was specifically
designed to promote uptake by addressing the barriers and
highlighting the benefits associated with the test. However, as the
leaflet supplemented the existing information (i.e., the standard
leaflet–which is balanced–, the consent form–which outlines the
risks of the procedure– and the face to face counseling–during
which the risks are discussed with a specialist screening practi-
tioner and which the individual must undergo prior to the
screening procedure–), the requirements of consent when making
a screening decision were still met in accordance with the General
Medical Council guidelines (General Medical Council, 2008).
Nonetheless, to examine satisfaction with the reminder leaflet, we
will use waiting room questionnaires and compare responses with
individuals receiving the standard NHS leaflet in the subsequent
RCT.
At last, it is important to note that in the UK, one in six people
have a reading level below that expected of an 11-year old (Harding
et al, 2012); therefore, the leaflet may still have been too difficult
for some people to read. Reducing the readability of written
information further may have benefits over and above those of the
current interventions used within our study; however, for these
adults written materials may not be the most suitable. Researchers
seeking to reduce inequalities should focus on alternative channels
of engaging these adults, such as through community outreach and
telephone intervention.
CONCLUSION
This study found that a locally tailored information leaflet and
mailed reminder letter, with options for the day and time of the
appointment and the gender of the practitioner performing the
test, was feasible, efficacious and exceeded a minimum level of
efficacy needed to merit further investigation in a RCT.
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